Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

The $310 million mid-cap value fund Putnam Equity Spectrum ( PYSAX) boasts a return of 14.6% this year.

Its top holding, EchoStar ( SATS), at 15% of the fund, is up 42% this year. The company operates a digital set-top box business for use by the cable TV industry, and a satellite-services business, which owns or leases eight orbiting satellites that lease capacity to businesses and government agencies.

Dish Network ( DISH), which is 14.3% of the portfolio, is up 45% this year. It provides broadcast services to 14.2 million customers in the U.S. via a network of owned and leased satellites. It acquired video-rental chain Blockbuster out of bankruptcy this year.

United Continental Holdings ( UAL), at 6.4% of the fund, is up 0.7% this year. It is the largest U.S. airline and operates nearly 6,000 daily flights, domestically and internationally.


The $991 million Delaware Smid Cap Growth Fund ( DFCIX) has advanced 14.2% this year, including 3.9% over the past three months.

Weight Watchers International ( WTW), at 6.5% of the fund, is its largest holding. Its shares are up 95% this year. The company offers a variety of weight-management products and services that encourage healthy weight loss through exercise, nutrition and portion control.

Polycom ( PLCM), the second-largest holding of the fund at 5.3%, is up 51% this year. It makes voice- and video-communications equipment.

Shares of Terradata ( TDC), which make up 2.4% of fund assets, are up 40% this year. The company is focused on developing and commercializing data warehousing solutions for large corporations and government agencies.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

If you liked this article you might like

Big Stock-Fund Ratings Changes

Big Stock-Fund Ratings Changes

Health Care Funds Suffer Amid Insurer Warnings

Health Care Sector Funds Get a Checkup

Health Care Sector Funds Get a Checkup

Best, Worst in Health Care and Biotech Funds